Phosphorylation of gH2AX as a novel prognostic biomarker for laryngoesophageal dysfunction-free survival
-
- María José de Miguel-Luken
- Department of Medical Oncology, Virgen del Rocío University Hospital, Seville, Spain
-
- Manuel Chaves-Conde
- Department of Medical Oncology, Virgen del Rocío University Hospital, Seville, Spain
-
- Begoña Quintana
- Department of Radiation Oncology, Virgen del Rocío University Hospital, Seville, Spain
-
- Alicia Menoyo
- Department of Otorhinolaryngology, Virgen del Rocío University Hospital, Seville, Spain
-
- Isabel Tirado
- Department of Otorhinolaryngology, Virgen del Rocío University Hospital, Seville, Spain
-
- Verónica de Miguel-Luken
- University of Málaga, Málaga, Spain
-
- Jerónimo Pachón
- Department of Radiation Oncology, Virgen del Rocío University Hospital, Seville, Spain
-
- David Chinchón
- Department of Pathology, Virgen del Rocío University Hospital, Seville, Spain
-
- Vladimir Suarez
- Department of Radiation Oncology, Virgen del Rocío University Hospital, Seville, Spain
-
- Amancio Carnero
- Instituto de Biomedicina de Sevilla, IBIS/Hospital Universitario Virgen del Rocío/ Universidad de Sevilla/ Consejo Superior de Investigaciones Científicas, Seville, Spain
書誌事項
- 公開日
- 2016-05-04
- DOI
-
- 10.18632/oncotarget.9172
- 公開者
- Impact Journals, LLC
収録刊行物
-
- Oncotarget
-
Oncotarget 7 (22), 31723-31737, 2016-05-04
Impact Journals, LLC
